Gadobenate dimeglumine has proved advantageous compared with other gadolinium-based contrast agents for contrast-enhanced brain MR imaging. Gadobutrol is a more highly concentrated agent (1.0 mol/L). This study intraindividually compared 0.1-mmol/kg doses of these agents for qualitative and quantitative evaluation of brain tumors.
Seidl, Z., Vymazal, J., Mechl, M., Goyal, M., Herman, M., Colosimo, C., Pasowicz, M., Yeung, R., Paraniak Gieszczyk, B., Yemen, B., Anzalone, N., Citterio, A., Schneider, G., Bastianello, S., Ruscalleda, J., Does higher gadolinium concentration play a role in the morphologic assessment of brain tumors? Results of a multicenter intraindividual crossover comparison of gadobutrol versus gadobenate dimeglumine (the MERIT Study), <<AJNR. American journal of neuroradiology>>, 2012; 33 (6): 1050-1058. [doi:10.3174/ajnr.A3033] [http://hdl.handle.net/10807/41146]
Does higher gadolinium concentration play a role in the morphologic assessment of brain tumors? Results of a multicenter intraindividual crossover comparison of gadobutrol versus gadobenate dimeglumine (the MERIT Study)
Colosimo, Cesare;
2012
Abstract
Gadobenate dimeglumine has proved advantageous compared with other gadolinium-based contrast agents for contrast-enhanced brain MR imaging. Gadobutrol is a more highly concentrated agent (1.0 mol/L). This study intraindividually compared 0.1-mmol/kg doses of these agents for qualitative and quantitative evaluation of brain tumors.
| File | Dimensione | Formato | |
|---|---|---|---|
|
1050.full.pdf
accesso aperto
Tipologia file ?:
Versione Editoriale (PDF)
Licenza:
Creative commons
Dimensione
2.02 MB
Formato
Adobe PDF
|
2.02 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
